Pay in 4 interest-free payments of $5.87 Learn more
Ships within 48 hours · Estimated delivery Aug 18 - Aug 23
GLP-1 Receptor Agonist Market Insights, By Drug Class: Liraglutide Contributes the Highest Share of the Market Owing to its Effectiveness and Superior Efficacy In terms of drug type, liraglutide is expected to contribute 26.5% share of the market in 2026, as its once-daily subcutaneous administration provides consistent glycemic control throughout the day
doi: 10.1007/s12291-009-0017-y 6
It has also been used strategically on drugs where the pediatric indication is commercially negligible but the six-month exclusivity extension on a billion-dollar adult drug is extremely valuable
2023;e2319574
US$ 25.81
US$ 26.17
US$ 21.16
US$ 23.76
US$ 22.58
US$ 27.33
US$ 22.07
US$ 27.22
US$ 26.76
